ULTRAGENYX PHARMACEUTICAL IN

Ticker: RARE CUSIP: 90400D108 Class: EQTY

MPM BioImpact LLC's Holding History (CIK: 0001687078)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 395,700 Value ($000) $11,903 Avg Close $29.99 Range $25.81 - $42.37

Q2 2025

Shares 395,700 Value ($000) $14,388 Avg Close $36.05 Range $29.59 - $40.19

Q1 2025

Shares 398,445 Value ($000) $14,428 Avg Close $41.60 Range $35.53 - $46.50

Q4 2024

Shares 391,018 Value ($000) $16,450 Avg Close $49.61 Range $41.26 - $57.99

Q3 2024

Shares 329,733 Value ($000) $18,317 Avg Close $50.94 Range $39.65 - $60.37

Q2 2024

Shares 380,552 Value ($000) $15,641 Avg Close $42.70 Range $37.02 - $52.56

Q1 2024

Shares 245,590 Value ($000) $11,467 Avg Close $47.17 Range $41.87 - $54.56

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	395,700	$11,903	$29.99	$25.81 - $42.37
Q2 2025	395,700	$14,388	$36.05	$29.59 - $40.19
Q1 2025	398,445	$14,428	$41.60	$35.53 - $46.50
Q4 2024	391,018	$16,450	$49.61	$41.26 - $57.99
Q3 2024	329,733	$18,317	$50.94	$39.65 - $60.37
Q2 2024	380,552	$15,641	$42.70	$37.02 - $52.56
Q1 2024	245,590	$11,467	$47.17	$41.87 - $54.56